BlackRock Institutional Trust’s Corbus Pharmaceuticals CRBP Stock Holding History

BlackRock Institutional Trust’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.61M	Buy	18,180 +10,975	+152%	+$2.52M	﹤0.01%	2758
2016 Q3	$1.47M	Buy	7,205 +900	+14%	+$112K	﹤0.01%	3159
2016 Q2	$566K	Hold	6,305	–	–	﹤0.01%	3471
2016 Q1	$342K	Hold	6,305	–	–	﹤0.01%	3531
2015 Q4	$312K	Buy	6,305 +178	+3%	+$9.07K	﹤0.01%	3582
2015 Q3	$289K	Buy	6,127 +6,020	+5,626%	+$401K	﹤0.01%	3589
2015 Q2	$10K	Buy	+107	New	+$10.8K	﹤0.01%	3876

Other funds holding CRBP

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock Institutional Trust's CRBP Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Corbus Pharmaceuticals (CRBP) stake by 152% in Q4 2016, buying an estimated $2.52M and bringing the position to 18,180 shares worth $4.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

BlackRock Institutional Trust first reported a position in CRBP in Q2 2015 and has held it in 7 quarters since. 49 funds tracked by Wall St. Rank hold CRBP as of Q4 2016.

BlackRock Institutional Trust held 18,180 shares of Corbus Pharmaceuticals worth $4.61M as of Q4 2016.
BlackRock Institutional Trust bought 10,975 Corbus Pharmaceuticals shares in Q4 2016, an estimated $2.52M.
Corbus Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2758 holding.
BlackRock Institutional Trust first reported a position in Corbus Pharmaceuticals in Q2 2015 and has held it in 7 quarters since.
49 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.